In this episode, the host explores Linus Petersson's unique approach to prolonging life, his forthcoming book on anti-ageing science, and his perspective on ageing as a disease. The conversation covers topics such as rapamycin, metformin, and innovative transplantation techniques, along with the societal impacts of extended healthspans and the role of AI in longevity research. With the formation of the Swedish Longevity Cluster, the once-lonely landscape has transformed into a thriving community, though much work remains to be done.

Key Points:

This episode highlights Linus Petersson's insights on extending life, his new book on anti-ageing, and the latest advances in longevity research. The growing community around the Swedish Longevity Cluster is also discussed.

• Understanding ageing as a Disease: Linus Petersson discusses why ageing should be classified as a disease, arguing that such a classification would encourage pharmaceutical development aimed at extending healthy lifespans and shift public perception towards viewing ageing as a preventable condition.
• Scientific Foundations for Longevity Research: The episode delves into the scientific methods and biological principles that support the possibility of significantly extending human lifespan, emphasizing that no physical or chemical laws prevent us from halting or reversing ageing processes.
• The Role of the Swedish Longevity Cluster: Linus introduces the Swedish Longevity Cluster, an organization he co-founded to promote longevity research and development in the Nordic countries, aiming to create a thriving ecosystem of startups and researchers focused on combating ageing.
• Potential Anti-ageing Therapies: The discussion includes various approaches to longevity, such as pharmaceuticals (e.g., rapamycin, metformin), gene therapy, and cutting-edge techniques like growing non-sentient bodies for organ replacement, which could potentially offer more comprehensive solutions to age-related decline.
• Challenges and Future Directions in ageing Research: Linus explains the need for better biomarkers to accurately measure biological age and assess the effectiveness of anti-ageing interventions. He also highlights the importance of developing a more robust scientific understanding of ageing at a cellular level.
• The Impact of AI on Longevity Science: The potential role of artificial intelligence in accelerating longevity research is explored, particularly in drug discovery and modeling complex biological systems, which could lead to breakthroughs in understanding and potentially reversing ageing.